全文获取类型
收费全文 | 1315821篇 |
免费 | 97042篇 |
国内免费 | 2970篇 |
专业分类
耳鼻咽喉 | 18567篇 |
儿科学 | 43160篇 |
妇产科学 | 38787篇 |
基础医学 | 191501篇 |
口腔科学 | 36262篇 |
临床医学 | 111888篇 |
内科学 | 261068篇 |
皮肤病学 | 27141篇 |
神经病学 | 102801篇 |
特种医学 | 51393篇 |
外国民族医学 | 368篇 |
外科学 | 202977篇 |
综合类 | 28591篇 |
现状与发展 | 2篇 |
一般理论 | 302篇 |
预防医学 | 94828篇 |
眼科学 | 29615篇 |
药学 | 101068篇 |
9篇 | |
中国医学 | 3446篇 |
肿瘤学 | 72059篇 |
出版年
2018年 | 13204篇 |
2016年 | 11238篇 |
2015年 | 13089篇 |
2014年 | 17933篇 |
2013年 | 26560篇 |
2012年 | 36558篇 |
2011年 | 38865篇 |
2010年 | 22956篇 |
2009年 | 21658篇 |
2008年 | 37338篇 |
2007年 | 40220篇 |
2006年 | 40588篇 |
2005年 | 39724篇 |
2004年 | 38108篇 |
2003年 | 36814篇 |
2002年 | 36207篇 |
2001年 | 58835篇 |
2000年 | 60272篇 |
1999年 | 51363篇 |
1998年 | 14563篇 |
1997年 | 13042篇 |
1996年 | 13320篇 |
1995年 | 12539篇 |
1994年 | 11937篇 |
1993年 | 10985篇 |
1992年 | 41312篇 |
1991年 | 40637篇 |
1990年 | 40145篇 |
1989年 | 38961篇 |
1988年 | 36333篇 |
1987年 | 35535篇 |
1986年 | 33905篇 |
1985年 | 32280篇 |
1984年 | 24057篇 |
1983年 | 20925篇 |
1982年 | 12447篇 |
1981年 | 10980篇 |
1979年 | 22733篇 |
1978年 | 15945篇 |
1977年 | 13795篇 |
1976年 | 13016篇 |
1975年 | 14248篇 |
1974年 | 16756篇 |
1973年 | 16138篇 |
1972年 | 15392篇 |
1971年 | 14297篇 |
1970年 | 13269篇 |
1969年 | 12790篇 |
1968年 | 12037篇 |
1967年 | 10534篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
7.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
8.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
9.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
10.
多囊卵巢综合征(polycystic ovary syndrome,PCOS)是一种内分泌代谢紊乱综合征,临床表现高度异质性。肥胖是PCOS异质性临床表现之一,超过50%的PCOS患者超重或肥胖。肥胖型PCOS主要表现为高雄激素血症、中心型肥胖和糖脂代谢紊乱,非肥胖型PCOS主要表现为黄体生成激素(luteinizing hormone,LH)水平异常升高。尽管肥胖型和非肥胖型PCOS均存在内分泌代谢异常,然而肥胖可加重PCOS糖脂代谢紊乱;肥胖型PCOS还表现脂肪代谢的异常。综述肥胖型PCOS患者的临床特征、性激素水平、糖脂代谢特征,旨在为肥胖型和非肥胖型PCOS患者新的分型诊治提供参考。 相似文献